home / stock / mmedf / mmedf quote
Last: | $4.69 |
---|---|
Change Percent: | 33.24% |
Open: | $4.23 |
Close: | $4.69 |
High: | $4.99 |
Low: | $3.55 |
Volume: | 21,964,042 |
Last Trade Date Time: | 04/26/2021 04:55:41 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.69 | $4.23 | $4.69 | $4.99 | $3.55 | 21,964,042 | 04-26-2021 |
$3.52 | $2.895 | $3.52 | $3.57 | $2.67 | 14,749,907 | 04-23-2021 |
$2.13 | $2.21 | $2.13 | $2.21 | $2.1 | 1,013,707 | 04-22-2021 |
$2.1864 | $2.37 | $2.1864 | $2.37 | $2.075 | 1,432,681 | 04-21-2021 |
$2.24 | $2.34 | $2.24 | $2.3699 | $2.05 | 2,385,169 | 04-20-2021 |
$2.34 | $2.44 | $2.34 | $2.45 | $2.28 | 1,560,065 | 04-19-2021 |
$2.43 | $2.45 | $2.43 | $2.47 | $2.38 | 1,126,603 | 04-16-2021 |
$2.4501 | $2.45 | $2.4501 | $2.5 | $2.4 | 860,723 | 04-15-2021 |
$2.43 | $2.48 | $2.43 | $2.54 | $2.4 | 1,133,834 | 04-14-2021 |
$2.52 | $2.58 | $2.52 | $2.62 | $2.5 | 823,840 | 04-13-2021 |
$2.6032 | $2.7 | $2.6032 | $2.73 | $2.57 | 624,447 | 04-12-2021 |
$2.69 | $2.65 | $2.69 | $2.78 | $2.6063 | 659,922 | 04-09-2021 |
$2.61 | $2.65 | $2.61 | $2.7 | $2.5 | 963,436 | 04-08-2021 |
$2.62 | $2.81 | $2.62 | $2.81 | $2.5996 | 911,798 | 04-07-2021 |
$2.74 | $2.92 | $2.74 | $2.92 | $2.7182 | 1,173,587 | 04-06-2021 |
$2.89 | $3 | $2.89 | $3.0226 | $2.84 | 1,225,896 | 04-05-2021 |
$2.86 | $2.845 | $2.86 | $3.09 | $2.69 | 2,757,045 | 04-02-2021 |
$2.86 | $2.845 | $2.86 | $3.09 | $2.69 | 2,757,045 | 04-01-2021 |
$2.7895 | $2.32 | $2.7895 | $2.7895 | $2.32 | 2,034,611 | 03-31-2021 |
$2.28 | $2.293 | $2.28 | $2.4 | $2.21 | 2,135,647 | 03-30-2021 |
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine Company Name:
MMEDF Stock Symbol:
OTCMKTS Market:
NEW YORK, June 9, 2021 /CNW/ — Mind Medicine (MindMed) Inc. (NEO: MMED)(OTC:MMEDF)(DE: BGHM) (the “Company”), a leading clinical-stage pharmaceutical company and pioneer in the field of psychedelic inspired medicines, announces that J.R. Rahn, the Com...
Last week, Deepak Chopra revealed that he’d entered into a new partnership with MindMed (NEO: MMED) (OTCQB: MMEDF), which aligned with his continued interest in mind-body healing. MindMed is a clinical-stage biotech company that is researching psychedelic medicine. In his stat...